Treatment Nonexistent for Some Glioblastoma Patients
Study shows treatment more likely and improved survival at high-volume centers
Patients diagnosed at high-volume centers are up to 40 percent more likely to receive treatment for glioblastoma, according to a study from researchers at the University of Illinois at Chicago.
The study, which is one of the largest on glioblastoma treatment and outcomes, also shows that patients treated at high-volume centers live approximately three and one-half months longer than patients treated at low-volume centers.
Dr. Matthew Koshy, corresponding author on the paper, says this difference in outcomes is on par with results seen in phase III clinical trials—the last of which for glioblastoma was two years ago.
Click here to read more.
18th Meeting of WSSFN
June 24-27, 2019; New York
International Summer School Transnasal Endoscopic Surgery: From Sinuses to Skull Base
June 24-28, 2019; Brescia, Italy
The Society of University Neurosurgeons Annual Meeting
June 26-30, 2019; Dubrovnik, Croatia
2019 New England Neurosurgical Society Annual Meeting
June 27-29, 2019; Brewster, Mass.
Neurotrauma 2019 Symposium
June 28-July 3, 2019; Pittsburgh